Human Mast Cells Express the Hyaluronic-Acid-Binding Isoform of CD44 and Adhere to Hyaluronic Acid
- 31 March 2000
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 94 (3) , 173-178
- https://doi.org/10.1006/clim.1999.4830
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Phenotypic Characterization of Human Skin Mast Cells by Combined Staining with Toluidine Blue and CD AntibodiesJournal of Investigative Dermatology, 1998
- INTERACTION BETWEEN CD44 AND HYALURONIC ACID REGULATES HUMAN PROSTATE CANCER DEVELOPMENTJournal of Urology, 1998
- Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritisRheumatology International, 1997
- Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemiaLeukemia, 1997
- Interactions of Immature Human Mast Cells with Extracellular Matrix: Expression of Specific Adhesion Receptors and Their Role in Cell Binding to Matrix ProteinsJournal of Investigative Dermatology, 1996
- Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cellsEuropean Journal of Immunology, 1995
- Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.The Journal of Experimental Medicine, 1994
- Down‐regulation by tumor necrosis factor‐α of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanismEuropean Journal of Immunology, 1991
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987